This inventor holds 1 USPTO granted patent. Top assignee: Pharmacia Ab. Active years: 2003.
Company Filing History:
Years Active: 2003
Title: Christina Nathansen: Innovator in Transdermal Drug Delivery
Introduction
Christina Nathansen is a notable inventor based in Hillerod, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the area of transdermal drug delivery systems. His innovative approach focuses on the use of N-Acetyl-L-cysteine as a mucolytic agent, which has potential applications in improving respiratory health.
Latest Patents
Christina holds a patent for a device that facilitates the transdermal administration of N-Acetyl-L-cysteine. This patent, titled "Transdermally administered acetylcysteine as mucolytic agent," outlines a method for achieving a mucolytic effect in both humans and animals. The invention encompasses the use of N-Acetyl-L-cysteine, along with its salts, prodrugs, and metabolites, combined with pharmaceutically acceptable carriers to enhance therapeutic efficacy.
Career Highlights
Christina is associated with Pharmacia AB, where he has been instrumental in advancing research and development in drug delivery technologies. His work has contributed to the understanding of how transdermal systems can be optimized for better patient outcomes. With a focus on innovative solutions, he continues to push the boundaries of pharmaceutical science.
Collaborations
Throughout his career, Christina has collaborated with esteemed colleagues such as Ulla Hoeck and Bo Kreilgard. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their work in the pharmaceutical industry.
Conclusion
Christina Nathansen's contributions to transdermal drug delivery represent a significant advancement in the field of pharmaceuticals. His innovative patent and collaborative efforts highlight his commitment to improving health outcomes through scientific innovation.